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Frailty Transitions in the San Antonio Longitudinal Study
of Aging
Sara E. Espinoza, MD,*†‡§ Inkyung Jung, PhD,∥ and Helen Hazuda, PhD#‡§
OBJECTIVES: To examine frailty transitions in Mexican
American (MA) and European American (EA) older
adults.
DESIGN: Longitudinal, observational cohort study.
SETTING: Socioeconomically diverse neighborhoods in
San Antonio, Texas.
PARTICIPANTS: Three hundred twelve MA and 285 EA
community-dwelling older adults (65) with frailty infor-
mation at baseline (1992–1996) and transition information
at follow-up (2000/01) in the San Antonio Longitudinal
Study of Aging.
MEASUREMENTS: Five frailty characteristics (weight
loss, exhaustion, weakness, slowness, and low physical
activity), frailty score (0–5), and overall frailty state (non-
frail = 0 characteristics, prefrail = 1 or 2, frail = 3) were
assessed at baseline. Transitions (progressed, regressed, or
no change) were assessed for frailty score and state. Odds
ratios (ORs) of progression and regression in individual
characteristics were estimated using generalized estimating
equations adjusted for age, sex, ethnic group, socio-
economic status, comorbidity, diabetes, and follow-up
interval.
RESULTS: Diabetes mellitus with macrovascular compli-
cations (OR = 1.84, 95% confidence interval (CI) = 1.02–
3.33), fewer years of education (OR = 0.96, 95%
CI = 0.93–1.0) and follow-up interval (OR = 1.3, 95%
CI = 1.17–1.46) were significant predictors of progression
in any frailty characteristic. Mortality increased with
greater frailty state, and prefrail individuals were more
likely than frail individuals to regress.
CONCLUSION: Diabetes mellitus with macrovascular
complications and fewer years of education are important
predictors of progression in any frailty characteristic.
Because of greater risk of death than for the nonfrail state
and greater likelihood of regression than for the frail state,
the prefrail state may be an optimal target for interven-
tion. J Am Geriatr Soc 60:652–660, 2012.
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It has been hypothesized that frailty is a geriatric syn-drome that clinicians recognize in clinical settings and
that is characterized by decreased resilience to stressors,
causing increased risk for age-related complications and
outcomes.1 Validated criteria developed in the Cardiovascu-
lar Health Study (CHS) and defined as the presence of three
or more of five characteristics (weight loss, exhaustion, low
physical activity, weakness, and slowness) have operational-
ized the syndrome as a research construct.2 Frail individuals
have been shown to be at risk for adverse outcomes, such as
falls, disability, institutionalization, and death.2,3 A prefrail
state is defined as the presence of one or two of these char-
acteristics, and individuals who are prefrail are at higher
risk of adverse outcomes than those who are nonfrail.2
Previous studies have reported that transitions
between frailty states (nonfrail, prefrail, frail) are fairly
common, with individuals worsening or improving over
time.4,5 One study of frailty transitions over 4.5 years in
754 predominantly European-American (EA) participants
reported that 57% of participants had at least one transi-
tion over approximately 4.5 years (although the most com-
mon pattern was to remain in the baseline frailty state).4
In addition, although it was more common for individuals
to worsen in frailty state (rates up to 43%), improvement
to a less-frail state occurred (rates up to 23%). Frail indi-
viduals were more likely to remain frail than to improve.
In contrast, another study that followed Mexican-Ameri-
can (MA) participants for 10 years in the Hispanic Estab-
lished Populations for the Epidemiologic Study of the
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Elderly (H-EPESE) found that the majority of frail individ-
uals died during follow-up.5 Transitions in individual
frailty characteristics were not the primary focus of these
prior studies, and neither study was able to make direct
comparisons between MAs and EAs.
The purpose of the current study was to characterize
change in individual frailty characteristics and overall
frailty state in a longitudinal, biethnic cohort of commu-
nity-dwelling older adults. The San Antonio Longitudinal
Study of Aging (SALSA) cohort, comprising approximately
equal numbers of MAs and EAs, allows for direct ethnic
comparisons. Thus, study results may help to identify not
only frailty states and individual frailty characteristics that
are optimal targets for intervention to prevent or delay
worsening across frailty states, but also potential health
disparities in frailty transitions.
METHODS
Sample
Subjects were 597 participants in the SALSA baseline
examination (1992–1996) for whom data were available
to characterize change in at least one frailty characteristic
from baseline to follow-up. Follow-up examinations
occurred in 2000/01. This sample has been described pre-
viously.6,7 Ethnic groups were classified using a validated,
standardized algorithm.8 Seven hundred forty-nine partici-
pants completed the baseline examination (70.5% response
rate). At the follow-up examination, 474 of 599 surviving
participants completed the study (79.1% response rate).
The SALSA baseline and follow-up examinations
consisted of a comprehensive home-based assessment
conducted in the participant’s home and a performance-
based assessment conducted at a clinical research center.
Trained bilingual staff administered assessments in English
or Spanish according to participants’ preference. The insti-
tutional review board of the University of Texas Health
Science Center San Antonio approved the study, and all
subjects gave informed consent.
Frailty Characterization
Validated CHS criteria and standardization procedures2
were applied to the pooled SALSA sample; standardized
cutpoints have been published previously.6
Walking Speed
Subjects were timed in seconds as they walked 10 feet at
their usual pace starting from a standing position. Walking
speed was standardized based on median height and sex.
Participants in the slowest quintile for each sex group were
considered slow. If a participant was unable to walk, he or
she was considered slow.
Grip Strength
Grip strength was measured in kilograms using a handheld
dynamometer in the dominant hand and was standardized
based on body mass index (BMI) quartiles and sex. Partici-
pants in the lowest quintile for each sex group were consid-
ered weak.
Physical Activity
Self-reported physical activity over the previous year was
assessed using the Minnesota Leisure Time Physical Activ-
ity Questionnaire, which yields average energy expenditure
in kilocalories per week9 and was standardized based on
sex. Participants in the lowest quintile for each sex group
were considered to have low energy expenditure.
Exhaustion
Exhaustion was measured according to the Geriatric
Depression Scale10 question, “Do you feel full of energy?”
Subjects who responded “no” were considered exhausted.
Weight Loss
Weight loss was assessed according to the response to the
question, “In the last year have you gained or lost more
than 10 pounds?” Response choices were gained only, lost
only, gained and lost, and neither. Intentionality was not
assessed. Only participants who reported that they had lost
but not gained weight were considered to have lost weight.
Frailty state was classified as an ordinal trichotomous
variable (nonfrail = 0 characteristics, prefrail = 1 or 2,
frail =  3). Frailty score was calculated as the total num-
ber of frailty characteristics, ranging from 0 to 5 at the
baseline examination and 0 to 6 at follow-up, with a score
of 6 indicating death.
Worsening in frailty state from baseline to follow-up
was defined as change from nonfrail to prefrail or frail or
from prefrail to frail. Improvement in frailty status was
defined as change from frail to prefrail or nonfrail or from
prefrail to nonfrail. Worsening and improvement were also
measured for individual frailty characteristics. For example,
worsening in walking speed was defined as being classified
as slow at follow-up if the baseline classification was not
slow. Improvement was defined as being classified as not
slow at follow-up if the baseline classification was slow.
Missing Data
The analytical cohort excluded individuals who had miss-
ing data for all five frailty characteristics at baseline or at
follow-up and those whose change (worsened, improved,
or unchanged) in at least one frailty characteristic from
baseline to follow-up could not be determined. Individuals
whose change in all frailty characteristics could not be
determined because of missing information were excluded.
Some data for individual frailty characteristics was missing
in the analytical cohort at baseline and follow-up for each
frailty characteristic. At baseline, 92.3% of the analytical
cohort had no missing frailty data, 6.4% were missing
data for one characteristic, and the remaining 1.3% were
missing data for two or three characteristics. At follow-up,
83.6% had no missing frailty information, 15.1% were
missing information for one characteristic, and 1.3% were
missing information for two or three characteristics.
Vital Status
Death was ascertained according to regular review of local
newspaper obituaries, San Antonio Metropolitan Health
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District vital statistics records, search of the Social Security
Death Index, and search of the National Death Index.
Covariates
Chronic Diseases
Chronic diseases measured at baseline were used as cova-
riates in the longitudinal analyses. Diabetes mellitus was
assessed using the American Diabetes Association criteria
based on a fasting plasma glucose level of 126 mg/dL or
greater or currently taking antidiabetic medication(s).11
Blood pressure was measured using a random-zero sphyg-
momanometer with the participant seated after a 5-min-
ute rest. Three measures were taken, and blood pressure
was calculated as the average of the second and third
readings. Hypertension was assessed using guidelines from
the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure six
guidelines.12 Ischemic heart disease (IHD) was assessed
by evaluation of a 12-lead electrocardiograph (ECG) for
the presence of ischemic ECG abnormalities. These
included presence of Q-waves of at least 0.04 seconds in
duration in leads II, III, and aVF or Q-waves in the pre-
cordial leads (V1 V6).
13 Self-reported IHD, or angina pec-
toris, was assessed using the validated and standardized
Rose questionnaire.14 Diabetes mellitus with macrovascu-
lar complications was defined as the presence of diabetes
mellitus with IHD or stroke. For the purposes of this
article, uncomplicated diabetes mellitus was defined as
presence of diabetes mellitus without IHD or stroke.
Chronic obstructive pulmonary disease was assessed
according to Global Initiative for Chronic Obstructive
Lung Disease criteria.15 Arthritis, cancer (nonskin), con-
gestive heart failure, and stroke were assessed according
to self-report of physician-diagnosed disease. Comorbid
disease was calculated as the presence of two or more
of the above diseases, excluding diabetes mellitus,
which was considered separately because of its three
times greater prevalence in MAs than EAs and prior
evidence that diabetes mellitus is a risk factor for
frailty.3,5
Cognitive Impairment
Cognitive impairment was assessed using the Folstein
Mini-Mental State Examination.16 Those with a score of
less than 18 were classified as cognitively impaired.
Socioeconomic Status
Monthly household income and number of years of formal
education were assessed according to self-report.
Follow-Up Interval
Years to follow-up or death was included as a covariate in
the analyses. The average follow-up period in the overall
frailty analytic cohort was 6.4 years (range 0.2–9.7 years).
For participants who completed the follow-up examina-
tion, the average follow-up interval was 7.0 years (range
4.4–9.7 years). For those who died, the average follow-up
interval was 4.4 years (range 0.2–9. years 4).
Statistical Analysis
Ethnic differences in demographic, socioeconomic status
(SES), disease variables, and frailty characteristics were
compared using the chi-square statistic for categorical vari-
ables and two-sample t-tests for continuous variables that
follow a normal distribution. The Wilcoxon two-sample
test was used for continuous variables that followed a
nonnormal distribution.
A generalized estimating equation (GEE) approach for
logistic regression for correlated outcomes was used to
estimate the odds of worsening in individual frailty charac-
teristics at follow-up, with death at follow-up considered
to be worsening in all five characteristics. GEE accounts
for correlations between different frailty characteristics
within an individual and uses all available data points to
model the marginal probability of worsening of each char-
acteristic. Three models were estimated, adding pertinent
covariates in each subsequent model. Model 1 was an
unadjusted model; Model 2 was adjusted for ethnic group,
age, sex, and follow-up interval; and Model 3 additionally
adjusted for SES (income, education), comorbid disease,
and diabetes mellitus. To further analyze the role of diabe-
tes mellitus in frailty worsening, Model 4 included the
covariates from the previous model except that diabetes
mellitus with macrovascular complications and uncompli-
cated diabetes mellitus were entered as separate variables.
Diabetes mellitus with and without macrovascular compli-
cations were each compared with no diabetes mellitus as
the reference group. Analyses for Tables 1, 2, 3, and 4
were performed using STATA version 10.1 (Stata Corp.,
College Station, TX), and analyses for Table 5 were
performed using SAS version 9.1 (SAS Institute, Inc., Cary,
NC).
RESULTS
Figure 1 provides a flowchart of the sample included in
the analysis. Five hundred ninety-seven individuals had
information to determine change in at least one frailty
characteristic from baseline to follow-up. Individuals who
had died at follow-up were considered to have progressed
in all frailty characteristics. Baseline sample characteristics
are shown in Table 1. MAs were older and had lower SES
than EAs. Although there were no significant ethnic differ-
ences in comorbidity, MAs had a higher prevalence of
diabetes mellitus and diabetes mellitus with complications.
There was no significant ethnic difference in the presence
of hypertension, ischemic heart disease, chronic obstructive
pulmonary disease, stroke, arthritis, or comorbidity. MAs
were more likely to have cognitive impairment, although
the overall prevalence of cognitive impairment in the
cohort was low, at approximately 2%. More EAs (44.9%)
than MAs (36.8%) had comorbid disease (P = .049), and
the overall prevalence of comorbidity in the cohort was
40.6%. More MAs (12.1%) than EAs (6.3%) were frail,
but approximately equal proportions of both ethnic groups
were prefrail, and more EAs than MAs were nonfrail, but
ethnic differences in overall frailty state were not statisti-
cally significant.
Frailty score and frailty state at follow-up (including
death) are shown in Tables 2 and 3 according to baseline
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frailty score and frailty state. Of those who were prefrail
at baseline, 36.9% remained prefrail. Individuals with two
frailty characteristics were almost twice as likely to pro-
gress to frail as those with only one (24.3% vs 13.6%),
and those with only one characteristic were almost twice
as likely to regress as those with two (17.9% vs 10.5%).
The death rate was similar for frailty scores of 1 and 2
and was approximately 10% higher than among nonfrail
participants. Of those who were frail at baseline, whether
they had a frailty score of 3, 4, or 5, the dominant transi-
tion was to death. The transition to death for those who
were frail was more than twice that for those who were
prefrail. Nonetheless, of participants with only three frailty
characteristics, 32.4% regressed, whereas few individuals
with four or five characteristics regressed.
Table 4 shows the presence or absence of each frailty
characteristic (or death) at follow-up, stratified according
to presence of that characteristic at baseline. Transition to
death was almost twice as high for individuals with frailty
characteristics at baseline that were classified using perfor-
mance-based measures and low physical activity than for
those classified using self-report measures.
Adjusted and unadjusted odds of worsening in individ-
ual frailty characteristics are shown in Table 5. Weight
Table 1. Study Sample Characteristics: Individuals for Whom Transition Data, Including Death, Were Obtained at
Follow-Up 1
Characteristic
Mexican American
(n = 312)
European American
(n = 285)
Total
(N = 597)*
P-Value for Ethnic
Difference
Baseline
Age, mean ± SD (range 65–80) 69.1 (3.2) 70.2 (3.5) 69.6 (3.4) <.001
Female, n (%) 172 (55.1) 157 (55.1) 329 (55.1) .99
Hypertension, n (%) 148 (47.4) 144 (50.5) 292 (48.9) .45
Stroke, n (%) 34 (11.0) 18 (6.4) 52 (8.8) .046
Arthritis, n (%) 134 (43.1) 135 (47.7) 269 (45.3) .26
Self-reported ischemic heart disease,
n (%)
23 (7.4) 20 (7.0) 43 (7.3) .85
ECG-defined ischemic heart disease,
n (%)
45 (14.5) 46 (16.1) 91 (15.3) .57
Congestive heart failure, n (%) 0 (0.0) 1 (0.4) 1 (0.2) .29
Chronic obstructive pulmonary
disease, n
(%) (n = 583)
93 (30.7) 104 (37.1) 197 (33.8) .10
Diabetes mellitus, n (%) (n = 532) 99 (33.9) 25 (10.4) 124 (23.3) <.001
Diabetes with complications, n (%)
(n = 449)†
34 (15.0) 7 (3.2) 41 (9.1) <.001
Cognitive impairment, n (%)‡ 9 (2.9) 1 (0.4) 10 (1.7) .02
Comorbidity, n (%) (n = 571)§ 112 (36.8) 120 (44.9) 232 (40.6) .049
Comorbidity, score, mean ± SD
(range 0–5)
1.3 (1.0) 1.4 (1.0) 1.3 (1.0) .12
Income, category, mean ± SD (range
1–15)‖
10.7 (3.1) 12.9 (2.3) 11.8 (2.9) <.001
Education, years, mean ± SD (range
0–23)
9.4 (4.5) 13.4 (2.6) 11.3 (4.2) <.001
Frailty, n (%)
Weakness (n = 592) 78 (25.2) 39 (13.8) 117 (19.8) .001
Slowness (n = 596) 71 (22.8) 44 (15.5) 115 (19.3) .02
Exhaustion (n = 582) 71 (23.4) 100 (36.0) 171 (29.4) .001
Weight loss (n = 568) 45 (15.5) 35 (12.6) 80 (13.4) .33
Low physical activity (n=590) 70 (22.7) 43 (15.3) 113 (19.2) .02
Frailty, ordinal trichotomous, n (%) (n = 559)
Nonfrail 102 (35.3) 107 (52.6) 209 (37.4) .05
Prefrail 152 (52.6) 146 (54.1) 298 (53.3)
Frail 35 (12.1) 17 (6.3) 52 (9.3)
* Sample size of 597 includes individuals for whom information was available for all five frailty characteristics at baseline or follow-up and whose transi-
tion could be classified in at least one frailty characteristic at baseline and follow-up. Sample size may be lower for individual baseline characteristics
because missing data in which case, sample size is listed next to the characteristic.
† Defined as the presence of diabetes mellitus (defined by American Diabetes Association criteria) and of stroke (according to self-report of physician-diag-
nosed disease) or self-reported (assessed according to the Rose questionnaire) or electrocardiogram (ECG)-defined ischemic heart disease.
‡ Defined as a Mini Mental State Examination score of less than 18.
§ Defined as presence of two or more of seven chronic conditions, including angina pectoris, hypertension, myocardial infarction, stroke, arthritis, and can-
cer (non-skin). Comorbidity score is a sum of the number of these chronic diseases present.
‖ Monthly household income categories: 1 = $0–49, 2 = $50–99, 3 = $100–149, 4 = $150–199, 5 = $200–299, 6 = $300–399, 7 = $400–499, 8 = $500–
749, 9 = $750–999, 10 = $1,000–1,249, 11 = $1,250–1,499, 12 = $1,500–1,999, 13 = $2,000–2,499, 14 = $2,500–2,999, 15 = $3,000. Dollar equiva-
lents of annual household incomes are: 10 = $13,500, 11 = $16,500, 12 = $21,000, 13 = $27,000.
SD = standard deviation.
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loss was used as the reference category in all models
because it had the highest rate of progression and regres-
sion of the five frailty characteristics. As indicated in
Table 5, the dependent variable for the GEE analysis was
worsening in any of the five frailty characteristics. The pre-
dictor variables were age, sex, ethnic group, household
income, education, diabetes mellitus without complica-
tions, diabetes mellitus with complications, and comorbid
diseases excluding diabetes mellitus. In the unadjusted
model for worsening, the odds of worsening relative to
weight loss were lowest for grip strength, followed by
physical activity, walking speed, and exhaustion. In Model
2, age and follow-up interval were significant predictors of
worsening in any frailty characteristic, with a 4% greater
risk of worsening for each year of age and a 39% greater
risk of worsening in frailty for each year of follow-up. In
Model 3, diabetes mellitus and fewer years of education
were significant predictors of worsening. Diabetes mellitus
was associated with an approximately 40% greater risk of
worsening (OR = 1.38, 95% CI = 1.0–1.91), whereas each
year of education was associated with a 4% lower risk of
worsening (OR = 0.96, 95% CI = 0.92–1.0). In Model 4,
diabetes mellitus with macrovascular complications— but
not uncomplicated diabetes mellitus—was a significant pre-
dictor of worsening (OR = 1.84, 95% CI = 1.02–3.33).
The magnitude of the effect was higher for diabetes
mellitus with macrovascular complications than for undif-
ferentiated diabetes mellitus in Model 3 (OR = 1.38).
DISCUSSION
This study of frailty transitions over an average 6.4 years
in community-dwelling older MA and EA participants in
SALSA found that prefrail individuals with two baseline
frailty characteristics were more likely than those with
only one to worsen in frailty state. Similarly, those with
only one baseline characteristic were more likely to
improve than those with two. Follow-up death rates
increased according to poorer baseline frailty state, and
the rate was higher for frailty characteristics classified
based on performance-based measures and low physical
activity than for those classified based on self-reported
frailty measures. In GEE analyses of frailty worsening, sig-
nificant predictors were diabetes mellitus with macrovascu-
Table 2. Follow-Up Frailty Score and Death Status According to Baseline Frailty Score for Total Sample
(N = 597)
Follow-Up Frailty Score (n)
N (%)
Baseline Frailty Score
Nonfrail Prefrail Frail
0 (n = 228) 1 (n = 212) 2 (n = 105) 3 (n = 37) 4 (n = 12) 5 (n = 3)
0 (145) 94 (41.2) 38 (17.9) 11 (10.5) 2 (5.4) 0 (0.0) 0 (0.0)
1 (159) 68 (29.8) 67 (31.6) 20 (19.1) 3 (8.1) 1 (8.3) 0 (0.0)
2 (93) 26 (11.4) 34 (16.0) 24 (22.9) 7 (18.9) 1 (8.3) 1 (33.3)
3 (59) 9 (4.0) 27 (12.7) 16 (15.2) 6 (16.2) 1 (8.3) 0 (0.0)
4 (14) 1 (0.4) 2 (0.9) 9 (8.6) 2 (5.4) 0 (0.0) 0 (0.0)
5 (3) 0 (0.0) 1 (0.5) 0 (0.0) 0 (0.0) 1 (8.3) 0 (0.0)
Dead (124) 30 (13.2) 43 (20.3) 24 (22.9) 17 (46.0) 8 (66.7) 2 (66.7)
Analysis includes individuals for whom information was available for all five frailty characteristics and whose transition could be classified in at least one
frailty characteristic at baseline and follow-up.
Table 3. Follow-Up Frailty Category and Death Status According to Baseline Frailty Category for Total Sample
(N = 597)
Follow-Up Frailty Category (n)
n (%)
Baseline Frailty Category
Nonfrail (n = 209) Prefrail (n = 298) Frail (n = 52) Cannot Classify (n = 38)
Nonfrail (121) 79 (37.8) 37 (12.4) 1 (1.9) 4 (10.5)
Prefrail (201) 70 (33.5) 110 (36.9) 6 (11.5) 15 (39.5)
Frail (76) 6 (2.9) 49 (16.4) 10 (19.2) 11 (29.0)
Deceased (124) 30 (14.4) 67 (22.5) 27 (51.9) 0 (0.0)
Cannot classify (75) 24 (11.5) 35 (11.7) 8 (15.4) 8 (21.1)
Analysis includes individuals for whom information was available for all five frailty characteristics and whose transition could be classified in at least one
frailty characteristic at baseline and follow-up.
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lar complications, fewer years of education, and follow-up
interval. Individuals with undifferentiated diabetes mellitus
were approximately 40% more likely to progress in any
frailty characteristic. In Model 4, those who had diabetes
mellitus with macrovascular complications were 84%
more likely to worsen in any frailty characteristic than
those without diabetes mellitus. These findings suggest that
diabetes mellitus plays a pervasive role in worsening of
frailty, affecting all five frailty characteristics.
Previous studies have shown that diabetes mellitus is
associated with prevalent2 and incident3,5 frailty, and fast-
ing hyperglycemia is associated with frailty in individuals
without diabetes mellitus.17 Several studies support associ-
ations between frailty and insulin resistance and diabetes
mellitus.18 In particular, insulin resistance has been shown
to be predictive of incident frailty, and higher levels of gly-
cosylated hemoglobin is also associated with frailty.19
Frailty has also been linked with other diseases, such as
cardiovascular disease, congestive heart failure, peripheral
vascular disease, and stroke.20,21 Although more research
is needed to develop agreed-upon clinical criteria for iden-
tifying frailty in the clinical setting, in the future, perform-
ing a clinical frailty assessment at the onset of diabetes
mellitus in older adults may help identify those at risk
of frailty and lead to early initiation of preventive
interventions.
To the knowledge of the authors, this is the first study
to examine diabetes mellitus as a predictor of worsening in
individual frailty characteristics. In spite of the fact that
diabetes mellitus is two to three times as prevalent in MAs
as in EAs, no ethnic differences were found in worsening
in any frailty characteristic. It has previously been reported
that MAs are 60% less likely than EAs to develop incident
frailty (OR = 0.40, 95% CI = 0.23–0.72) after covariate
adjustment for relevant covariates,22 but the present find-
ings suggest that MAs and EAs may be equally likely to
transition in individual frailty characteristics and that fac-
tors predicting worsening of any frailty characteristic,
including diabetes mellitus, may operate similarly in both
ethnic groups.
This study also showed that fewer years of education,
an important indicator of SES, is also a significant predic-
tor of worsening in any individual frailty characteristic
(OR = 0.96, 95% CI = 0.93–1.0). Previous studies have
shown that low SES is associated with prevalent and inci-
dent frailty.2,3,23 A potential mechanism explaining this
association between low SES and frailty is inflammation,
which is thought to be a major physiological alteration
operant in frailty24 and which may result from poorer
nutritional status, less access to medical care, and higher
prevalence of chronic disease in individuals with lower
SES.25 The current study extends these findings by showing
that education is a predictor of worsening in any frailty
characteristic. In combination with the findings relative to
diabetes mellitus, there may be a greater burden of frailty
in older individuals with diabetes mellitus with lower
education. More research is needed, although it is possible
that education interventions in the area of diabetes mell-
itus management for older adults could indirectly reduce
frailty progression by lowering the incidence of diabetes
mellitus with complications.
Mortality was higher for individual frailty characteris-
tics classified using objective or quasi-objective measures
than for those that were self-reported. One possibility for
this finding is that individual perceptions or self-report bias
may affect more-objective measures of frailty, which may
be more reflective of underlying physiological deficits than
self-reported measures, less. Prior studies have shown that
individual frailty measures are predictive of mortality,26,27
although previous reports of which individual frailty
Table 4. Follow-Up (F/U) Status, Including Death, for Individual Frailty Characteristics According to Correspond-
ing Baseline Status
Individual Frailty Characteristic
n (%)
Exhibited Characteristic at Baseline Did Not Exhibit Characteristic at Baseline
Grip strength Weakness at baseline (n = 84) No weakness at baseline (n = 382)
Weakness at F/U 26 (30.9) Weakness at F/U 27 (7.1)
No weakness at F/U 24 (28.6) No weakness at F/U 271 (70.9)
Dead at F/U 34 (40.5) Dead at F/U 84 (22.0)
Walking speed Slowness at baseline (n = 82) No slowness at baseline (n = 384)
Slowness at F/U 28 (34.2) Slowness at F/U 37 (9.6)
No slowness at F/U 21 (25.6) No slowness at F/U 262 (68.2)
Dead at F/U 33 (40.2) Dead at F/U 85 (22.1)
Exhaustion Exhaustion at baseline (n = 138) No exhaustion at baseline (n = 328)
Exhaustion at F/U 71 (51.5) Exhaustion at F/U 50 (15.2)
No exhaustion at F/U 25 (18.1) No exhaustion at F/U 202 (61.6)
Dead at F/U 42 (30.4) Dead at F/U 76 (23.2)
Weight loss Weight loss at baseline (n = 65) No weight loss at baseline (n = 401)
Weight loss at F/U 21 (32.3) Weight loss at F/U 91 (22.7)
No weight loss at F/U 24 (36.9) No weight loss at F/U 212 (52.9)
Dead at F/U 20 (30.8) Dead at F/U 98 (24.4)
Physical activity Low physical activity at baseline (n = 84) No low physical activity at baseline (n = 382)
Low physical activity at F/U 22 (26.2) Low physical activity at F/U 24 (6.3)
No low physical activity at F/U 27 (32.1) No low physical activity at F/U 275 (72.0)
Dead at F/U 35 (41.7) Dead at F/U 83 (21.7)
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characteristics predict mortality vary between study popu-
lations and have included objective and self-reported char-
acteristics as the strongest mortality predictor.26–28
Because prefrail individuals may have only one frailty
characteristic but still be at significant risk of death and
incident frailty,2,6 the potential ability of individual frailty
characteristics to predict these outcomes in diverse
populations should continue to be examined to identify
appropriate targets for intervention in different population
subgroups.
The SALSA cohort was aged 69.6 ± 3.4 at baseline,
an average of 8.8 years younger than the cohort in a previ-
ous study4 (78.4 ± 5.3) and 12.9 years younger than the
H-EPESE cohort (82.5 ± 4.5).5 Despite these age differ-
ences, all studies found that frail individuals were unlikely
to regress. The SALSA and H-EPESE studies found that
frail individuals were more likely to die than remain frail,
whereas the other study,4 which followed participants for
a shorter time, found that frail individuals were more
likely to remain frail than die. The advanced age of the H-
EPESE cohort and slightly longer follow-up interval proba-
bly account for the greater proportion of frail individuals
who died in that study than in SALSA (84% vs 52%).
The present study has several limitations. There were
minor modifications of the CHS criteria. Results obtained
for MAs living in a single major urban area in south
Texas may not be generalizable to MAs living in other
urban areas in the United States or those living in rural
areas. The sample size was small, and only approximately
7% of the analytical cohort regressed in overall frailty
status. Bias could have been introduced if the individuals
lost to follow-up differed systematically from those who
completed the follow-up examination. To address this
concern, baseline frailty information for those included in
the analytical cohort was compared with that of non-
completers (data not shown); no differences were found
in individual frailty characteristics or frailty state between
the two groups. Disease ascertainment is also a potential
limitation. Although diabetes mellitus, hypertension, and
IHD were measured according to clinical criteria or vali-
dated measures, many were ascertained according to self-
report of physician-diagnosed disease and were not adju-
dicated. Finally, the varying length of follow-up among
SALSA participants was by design. Interval lengths were
varied across individuals by reversing the order of enroll-
ment at baseline to maximize information from the
assessment. Interval length was included as a covariate in
the GEE analyses.
The findings of greater mortality in prefrail than non-
frail individuals, approximately equivalent death rates in
prefrail individuals with one or two frailty characteristics,
and a substantially lower death rate in prefrail than frail
individuals provides further validation of the trichotomous
frailty classification proposed by Fried in the CHS,2 high-
Table 5. Likelihood of Frailty Worsening (vs Remaining Unchanged or Improving) in Multivariate Models Using
Generalized Estimating Equations (GEEs) (N = 597)
Variable
Odds Ratio (95% Confidence Interval) P-Value
Model 1 Model 2 Model 3 Model 4
Dependent variable
Grip strength 0.56 (0.47–0.66)
<.001
0.3 (0.21–0.43)
<.001
0.28 (0.19–0.41)
<.001
0.28 (0.19–0.41)
<.001
Walking speed 0.65 (0.55–0.77)
<.001
0.39 (0.27–0.56)
<.001
0.40 (0.27–0.58)
<.001
0.4 (0.27–0.58)
<.001
Exhaustion 0.73 (0.61–0.88)
.001
0.57 (0.41–0.81)
.001
0.54 (0.37–0.78)
.001
0.54 (0.37–0.78)
.001
Physical activity 0.59 (0.49–0.70)
<.001
0.36 (0.25–0.51)
<.001
0.36 (0.25–0.52)
<.001
0.36 (0.25–0.52)
<.001
Weight loss 1 1 1 1
Predictor variable
Ethnicity (Mexican American vs European American) 1.05 (0.82–1.36) .68 0.78 (0.56–1.07) .09 0.76 (0.56–1.05) .09
Age 1.04 (1.00–1.08) .05 1.04 (1.00–1.08) .06 1.04 (1.00–1.08) .06
Sex (male vs female) 1.11 (0.86–1.42) .42 1.21 (0.92–1.59) .23 1.20 (0.91–1.58) .19
Follow-up interval, years 1.39 (1.26–1.54)
<.001
1.30 (1.17–1.46)
<.001
1.30 (1.17–1.46)
<.001
Income (1-category increment)* – – 0.95 (0.90–1.01) .09 0.96 (0.91–1.01) .11
Education (1-year increment) – – 0.96 (0.93–1.0) .04 0.96 (0.93–1.0) .04
Comorbidity (not including diabetes mellitus) – – 1.30 (0.99–1.71) .06 1.26 (0.95–1.67) .11
Diabetes mellitus (yes vs no) – – 1.38 (1.00–1.91) .05
Diabetes mellitus without complications (vs no
diabetes mellitus)
– – 1.25 (0.88–1.79) .21
Diabetes mellitus with complications (vs no
diabetes mellitus)†
– – 1.84 (1.02–3.33) .04
The GEE analysis includes all subjects whose change in at least one of the five frailty characteristics can be determined.
* Monthly household income categories: 1 = $0–49, 2 = $50–99, 3 = $100–149, 4 = $150–199, 5 = $200–299, 6 = $300–399, 7 = $400–499, 8 = $500–
749, 9 = $750–999, 10 = $1,000–1,249, 11 = $1,250–1,499, 12 = $1,500–1,999, 13 = $2,000–2,499, 14 = $2,500–2,999, 15 = $3,000.
† Defined as the presence of diabetes mellitus (defined by American Diabetes Association criteria) and the presence of stroke (defined according to self-
report of physician-diagnosed disease) or self-reported (assessed by Rose questionnaire) or electrocardiogram-defined ischemic heart disease.
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lighting the significance of prefrailty as a separate risk
state. Furthermore, the finding that prefrail individuals
were more likely than frail individuals to improve in frailty
state suggests that this group of individuals is capable of
significant improvement over time and may be responsive
to clinical and behavioral interventions to slow or reverse
worsening of frailty.
Although there is no established clinical intervention
for frailty per se, characteristics of the frailty phenotype
include physical activity, muscle strength, and nutrition.
One study has shown that physical activity, in the form of
strength training, is more effective than a nutritional inter-
vention in improving muscle strength and gait speed in older
adults and that it is safe, even in nursing home residents.29
Other studies have shown that exercise interventions can
ameliorate frailty and prevent disability in frail older
adults,30 but there are conflicting findings regarding the
effectiveness of therapeutic exercise, as well as the specific
type of exercise that should be recommended to older
adults.31 Future research should focus on translating exer-
cise and strength training interventions into clinical prescrip-
tions for therapeutic exercise in older adults and testing and
translating into clinical practice various approaches to
frailty screening in the clinical setting. Given the increasing
rates of diabetes mellitus in the U.S. population, including
older adults, the role of diabetes mellitus in the development
of frailty is an important concern and should be considered
when developing methods and interventions for improving
the health of older adults in the future.
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